In the TME, the surface of M1 macrophages is rich in TLR2/TLR4, CD80, CD86, CD40, CSF1, IL-1R1, INF-γ-R and MHC-II receptors (Figure 3), which are often used as targets for cancer therapy [156,157,158]. Here, CD40 is linked to cancer.